Yang Ling
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Otorhinolaryngology top 10%
Papers in
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- Oncology 10
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Changsong Zhang (11 shared papers)Hua‐Jie Dong (2 shared papers)Yongping Liu (8 shared papers)Changtai Zhu (5 shared papers)Xujing Lu (2 shared papers)Xifa Zhou (2 shared papers)Judong Luo (3 shared papers)Jia Chen (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)PLoS ONE (3 papers)Frontiers in Medicine (2 papers)Frontiers in Bioscience-Landmark (1 paper)Trials (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yang Ling
43 papers receiving 560 citations
Peers
Comparison fields: 5 of 75
- Hepatology 52
- Otorhinolaryngology 22
- Sensory Systems 23
- Cancer Research 69
- Oncology 124
Countries citing papers authored by Yang Ling
This map shows the geographic impact of Yang Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ling more than expected).
Fields of papers citing papers by Yang Ling
This network shows the impact of papers produced by Yang Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ling. The network helps show where Yang Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 84 | |
| 2 | 2014 | 41 | |
| 3 | 2013 | 36 | |
| 4 | 2013 | 35 | |
| 5 | 2017 | 35 | |
| 6 | 2014 | 30 | |
| 7 | 2012 | 29 | |
| 8 | 2012 | 28 | |
| 9 | 2014 | 25 | |
| 10 | 2010 | 24 | |
| 11 | 2023 | 20 | |
| 12 | 2013 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2020 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2018 | 12 | |
| 17 | 2021 | 11 | |
| 18 | [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy]. | 2011 | 11 |
| 19 | 2013 | 8 | |
| 20 | 2017 | 8 |
About Yang Ling
Yang Ling is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 44 papers that have together received 566 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (3 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Hepatology (52 citations), Otorhinolaryngology (22 citations), Sensory Systems (23 citations), Cancer Research (69 citations) and Oncology (124 citations). Yang Ling has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Changsong Zhang, Hua‐Jie Dong, Yongping Liu, Changtai Zhu, Xujing Lu, Xifa Zhou, Judong Luo, Jia Chen, Feng Wang and Xizhi Zhang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Frontiers in Medicine, Frontiers in Bioscience-Landmark and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.